Cns Pharmaceuticals Inc [NASDAQ: CNSP] gained 10.46% or 0.01 points to close at $0.10 with a heavy trading volume of 37215613 shares.
The daily chart for CNSP points out that the company has recorded -40.86% loss over the past six months.
If we look at the average trading volume of 15.31M shares, CNSP reached to a volume of 37215613 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cns Pharmaceuticals Inc [CNSP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CNSP shares is $2.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CNSP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Cns Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 28, 2020. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 24, 2020, representing the official price target for Cns Pharmaceuticals Inc stock.
The Average True Range (ATR) for Cns Pharmaceuticals Inc is set at 0.01 The Price to Book ratio for the last quarter was 1.03, with the Price to Cash per share for the same quarter was set at 0.12.
Trading performance analysis for CNSP stock
Cns Pharmaceuticals Inc [CNSP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.59. With this latest performance, CNSP shares dropped by -10.78% in over the last four-week period, additionally sinking by -40.86% over the last 6 months – not to mention a drop of -99.15% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CNSP stock in for the last two-week period is set at 50.36, with the RSI for the last a single of trading hit 54.84, and the three-weeks RSI is set at 46.84 for Cns Pharmaceuticals Inc [CNSP]. The present Moving Average for the last 50 days of trading for this stock 0.1073, while it was recorded at 0.0965 for the last single week of trading, and 1.9652 for the last 200 days.
Cns Pharmaceuticals Inc [CNSP]: A deeper dive into fundamental analysis
Cns Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.81 and a Current Ratio set at 1.81.
Cns Pharmaceuticals Inc [CNSP]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CNSP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cns Pharmaceuticals Inc go to 92.16%.
An analysis of Institutional ownership at Cns Pharmaceuticals Inc [CNSP]
There are presently around $0.79%, or 0.80%% of CNSP stock, in the hands of institutional investors.
